Mark Massaro's Stock Ratings

BTIG Analyst

Mark Massaro is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/01/2024

Overall Average Return

-1.56%

Smart Score

54.5%

Overall Average Return Percentile

34th

Number of Ratings

68
Buy NowGet Alert
05/16/2024BNGOBuy Now
Bionano Genomics
$0.99102.02%$3 → $2MaintainsBuyGet Alert
05/15/2024DNABuy Now
Ginkgo Bioworks Holdings
$0.53——DowngradeNeutral → SellGet Alert
05/14/2024AKYABuy Now
Akoya Biosciences
$2.07189.86%$9 → $6MaintainsBuyGet Alert
05/13/2024NTRABuy Now
Natera
$106.5317.34%$100 → $125MaintainsBuyGet Alert
05/09/2024EXASBuy Now
Exact Sciences
$45.4576.02%$85 → $80MaintainsBuyGet Alert
05/02/2024NEOBuy Now
NeoGenomics
$13.7153.17%$23 → $21MaintainsBuyGet Alert
04/30/2024WGSBuy Now
GeneDx Hldgs
$19.75-3.8%$15 → $19MaintainsBuyGet Alert
04/22/2024WGSBuy Now
GeneDx Hldgs
$19.75-24.05%$11 → $15MaintainsBuyGet Alert
04/04/2024ADPTBuy Now
Adaptive Biotechnologies
$3.4544.93%$6 → $5MaintainsBuyGet Alert
03/14/2024HLTHBuy Now
Cue Health
$0.07——DowngradeBuy → NeutralGet Alert
03/13/2024MXCTBuy Now
MaxCyte
$4.4778.97%$10 → $8MaintainsBuyGet Alert
03/12/2024TKNOBuy Now
Alpha Teknova
$1.79——DowngradeBuy → NeutralGet Alert
03/07/2024DMTKBuy Now
DermTech
$0.33502.41%$4 → $2MaintainsBuyGet Alert
03/07/2024MDXHBuy Now
MDxHealth
$2.71195.2%$7 → $8MaintainsBuyGet Alert
03/06/2024SOPHBuy Now
Sophia Genetics
$5.1056.86%$7 → $8MaintainsBuyGet Alert
12/29/2023NEOBuy Now
NeoGenomics
$13.7153.17%$25 → $21MaintainsBuyGet Alert
12/29/2023NTRABuy Now
Natera
$106.53-20.21%$75 → $85MaintainsBuyGet Alert
11/09/2023DNABuy Now
Ginkgo Bioworks Holdings
$0.53——DowngradeBuy → NeutralGet Alert
08/16/2023TLISBuy Now
Talis Biomedical
$8.70-42.53%$0.35 → $5MaintainsSellGet Alert
08/10/2023BNGOBuy Now
Bionano Genomics
$0.99910.1%$2 → $10MaintainsBuyGet Alert
08/07/2023DMTKBuy Now
DermTech
$0.331406.02%$6 → $5MaintainsBuyGet Alert
06/15/2023CSTLBuy Now
Castle Biosciences
$23.2628.98%$38 → $30MaintainsBuyGet Alert
05/18/2023BNGOBuy Now
Bionano Genomics
$0.99102.02%$30 → $20MaintainsBuyGet Alert
05/16/2023MDXHBuy Now
MDxHealth
$2.71158.3%$8 → $7MaintainsBuyGet Alert
05/15/2023HLTHBuy Now
Cue Health
$0.074404.5%$5 → $3MaintainsBuyGet Alert
05/09/2023NEOBuy Now
NeoGenomics
$13.7182.35% → $25UpgradeNeutral → BuyGet Alert
04/24/2023BNGOBuy Now
Bionano Genomics
$0.99203.03%$30 → $30MaintainsBuyGet Alert
04/20/2023MDXHBuy Now
MDxHealth
$2.71195.2%$8 → $8MaintainsBuyGet Alert
04/03/2023RNLXBuy Now
Renalytix
$0.42723.72%$4 → $3.5MaintainsBuyGet Alert
03/22/2023XGNBuy Now
Exagen
$1.96155.1%$6 → $5MaintainsBuyGet Alert

Recent Analyst Stock Rating News

Key Takeaways From Natera Analyst Ratings
What Analysts Are Saying About DermTech Stock
What 6 Analyst Ratings Have To Say About NeoGenomics
NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
These Analysts Increase Their Forecasts On MDxHealth After Q4 Results
MDxHealth SA (NASDAQ: MDXH) reported better-than-expected sales for its fourth quarter on Wednesday.
Evaluating NeoGenomics: Insights From 4 Financial Analysts
A Glimpse Into The Expert Outlook On Natera Through 9 Analysts
Expert Ratings For Natera
Expedia To Rally Around 10%? Here Are 10 Top Analyst Forecasts For Friday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Illumina Now A Buy Following Q2 Beat, Improved Sales Outlook
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free